A citation-based method for searching scientific literature

Padma Sheila Rajagopal, Sarah Nielsen, Olufunmilayo I Olopade. JAMA Netw Open 2019
Times Cited: 4







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
75

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
564
75

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
50

Population Based Testing for Primary Prevention: A Systematic Review.
Ranjit Manchanda, Faiza Gaba. Cancers (Basel) 2018
14
50

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
52
50

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
110
50



TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, Paul K Marcom, Payal D Shah, Tarah J Ballinger, Eddy S Yang, Shaveta Vinayak,[...]. J Clin Oncol 2020
37
50

Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Leland E Hull, Jennifer S Haas, Steven R Simon. Am J Prev Med 2018
12
50

Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.
Katie E J Hann, Madeleine Freeman, Lindsay Fraser, Jo Waller, Saskia C Sanderson, Belinda Rahman, Lucy Side, Sue Gessler, Anne Lanceley. BMC Public Health 2017
80
50

Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study.
Tarsha Jones, Anne Marie McCarthy, Younji Kim, Katrina Armstrong. Cancer Med 2017
29
50

The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine.
Katie Stoll, Shobana Kubendran, Stephanie A Cohen. Am J Med Genet C Semin Med Genet 2018
54
25

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
231
25

Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.
S-W Kim, C S Lee, J V Fey, P I Borgen, J Boyd. J Med Genet 2005
7
25

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
25

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.
Rebecca C Fitzgerald, Richard Hardwick, David Huntsman, Fatima Carneiro, Parry Guilford, Vanessa Blair, Daniel C Chung, Jeff Norton, Krishnadath Ragunath, J Han Van Krieken,[...]. J Med Genet 2010
335
25

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Andrew Tutt, Holly Tovey, Maggie Chon U Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazinska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee,[...]. Nat Med 2018
295
25

Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Cynthia L Neben, Anjali D Zimmer, Will Stedden, Jeroen van den Akker, Robert O'Connor, Raymond C Chan, Elaine Chen, Zheng Tan, Annette Leon, Jack Ji,[...]. J Mol Diagn 2019
32
25

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
648
25

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
151
25

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
25

Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001
184
25

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi,[...]. JAMA 2018
159
25

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.
Shan Yang, Jennifer E Axilbund, Erin O'Leary, Scott T Michalski, Robbie Evans, Stephen E Lincoln, Edward D Esplin, Robert L Nussbaum. Ann Surg Oncol 2018
24
25


A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Li Sun, Adam Brentnall, Shreeya Patel, Diana S M Buist, Erin J A Bowles, D Gareth R Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey,[...]. JAMA Oncol 2019
31
25


Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
67
25

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
168
25

Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer.
A Ziogas, M Gildea, P Cohen, D Bringman, T H Taylor, D Seminara, D Barker, G Casey, R Haile, S Y Liao,[...]. Cancer Epidemiol Biomarkers Prev 2000
66
25


The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.
Padma Sheila Rajagopal, Daniel V T Catenacci, Olufunmilayo I Olopade. J Clin Oncol 2019
4
25

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox,[...]. J Natl Cancer Inst 2018
110
25

Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
Siddhartha Yadav, Fergus J Couch. Am Soc Clin Oncol Educ Book 2019
16
25


Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
25

The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
Yanin Chavarri-Guerra, Carolyn B Hendricks, Sandra Brown, Catherine Marcum, Mary Hander, Zdenka E Segota, Chris Hake, Sharon Sand, Thomas P Slavin, Arti Hurria,[...]. J Am Geriatr Soc 2019
5
25

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
175
25

Should All Patients With a Diagnosis of Breast Cancer Undergo Expanded Panel Testing?
Mehmet Sitki Copur, Pornchai Jonglertham, Thomas Zusag. J Clin Oncol 2019
4
25

Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al.
Peter Beitsch, Kevin Hughes, Pat Whitworth. J Clin Oncol 2019
1
100

Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Reinoutje Kaas, Senno Verhoef, Jelle Wesseling, Matti A Rookus, Hester S A Oldenburg, Marie-Jeanne Vrancken Peeters, Emiel J T Rutgers. Ann Surg 2010
51
25

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
25


Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
73
25


Population Testing for High Penetrance Genes: Are We There Yet?
Nicolas Wentzensen, Christine D Berg. J Natl Cancer Inst 2018
4
25


Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Mark Robson, Kathryn J Ruddy, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Wei Li, Nadine Tung, Anne Armstrong,[...]. Eur J Cancer 2019
21
25

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.
George Somlo, Paul H Frankel, Banu K Arun, Cynthia X Ma, Agustin A Garcia, Tessa Cigler, Leah V Cream, Harold A Harvey, Joseph A Sparano, Rita Nanda,[...]. Clin Cancer Res 2017
52
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.